var data={"title":"Clinical manifestations, diagnosis, and treatment of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations, diagnosis, and treatment of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/contributors\" class=\"contributor contributor_credentials\">Bruno Hoen, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 26, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>Streptococcus bovis</em><span class=\"nowrap\">/<em>Streptococcus</span> equinus </em>complex includes four major species that all belong to group D streptococci (GDS); this taxonomy was established in 2003 and is summarized in the Table (<a href=\"image.htm?imageKey=ID%2F89670\" class=\"graphic graphic_table graphicRef89670 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/1\" class=\"abstract_t\">1</a>]. For simplicity, the <em>Streptococcus bovis</em><span class=\"nowrap\">/<em>Streptococcus</span> equinus</em> complex will be referred to as GDS in the discussion below.</p><p>GDS are gram-positive cocci that are an important cause of bacteremia and infective endocarditis in adults. Because there is a strong association between infections with GDS and colonic neoplasms and other lesions of the gastrointestinal tract, evaluation of the gastrointestinal tract with colonoscopy is important for patients with infections due to this organism [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>].</p><p>GDS species and subspecies differ in their microbiology, pathogenesis, and epidemiology. Most clinical microbiology laboratories in the United States use automated testing equipment or other methods to identify these organisms to the species and subspecies level. However, some laboratories continue to report them under the common name <em>S. bovis</em> or <em>S. bovis</em> group [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Associations with endocarditis and colonic neoplasm are most closely linked to <em>Streptococcus gallolyticus</em> subspecies <em>gallolyticus</em> (<em>S. bovis</em> biotype I) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2,4-6\" class=\"abstract_t\">2,4-6</a>]. <em>S. bovis</em> biotype II bacteremias may be more associated with biliary tract disease and more likely to be polymicrobial [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/4,7\" class=\"abstract_t\">4,7</a>]. <em>S. gallolyticus</em> subspecies <em>pasteurianus</em> has been identified as a cause of infections in neonates and infants [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/8-10\" class=\"abstract_t\">8-10</a>]. However, the published literature regarding these organisms does not always distinguish GDS isolates to the biotype <span class=\"nowrap\">and/or</span> subspecies level consistently [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>]. Regardless, in studies in which GDS isolates were identified using 16S rRNA sequencing, both endocarditis and colorectal tumors were observed with all GDS subspecies [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/11\" class=\"abstract_t\">11</a>].</p><p>The clinical manifestations, diagnosis, and therapy of <em>S. bovis</em> infection will be reviewed here. The microbiology, pathogenesis, and epidemiology of GDS infection are discussed separately. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H24505889\"><span class=\"h1\">CLINICAL ASSOCIATIONS</span></p><p class=\"headingAnchor\" id=\"H24505897\"><span class=\"h2\">Association with endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Group D streptococci (GDS) account for 2 to 6 percent of streptococcal bloodstream isolates from hospitalized patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/12,13\" class=\"abstract_t\">12,13</a>]; the gastrointestinal tract is the most likely portal of entry [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/14\" class=\"abstract_t\">14</a>]. Almost all bacteremias caused by GDS are clinically significant [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/4\" class=\"abstract_t\">4</a>]. In a report of 92 patients with GDS bacteremia, 28 percent were found to have infective endocarditis (IE) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/15\" class=\"abstract_t\">15</a>].</p><p><em>S. gallolyticus</em> has the strongest association with colonic lesions and endocarditis; a meta-analysis demonstrated that patients with infection due to this organism had a strongly increased risk of colorectal cancer (pooled odds ratio [OR] 7.26; 95% CI 3.94-13.36) and endocarditis (pooled OR 16.61; 95% CI 2.03-6.81) compared with patients with <em>S. bovis</em> biotype II infection [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>].</p><p>In studies that discriminate to the subspecies level, IE was observed in 43 to 100 percent of patients infected with <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> (former <em>S. bovis</em> biotype I). The proportion of patients with IE and infection due to former <em>S. bovis</em> biotype II (<em>S. gallolyticus</em> subspecies <em>pasteurianus</em> and <em>S. infantarius</em>) was 8 to 29 percent, similar to viridans streptococci in some series [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2,16\" class=\"abstract_t\">2,16</a>]. GDS bacteremia in the absence of IE was frequently associated with former <em>S. bovis</em> biotype II (67 to 69 percent), polymicrobial bloodstream infection (44.0 to 53.5 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/7,16\" class=\"abstract_t\">7,16</a>], and biliary tract disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/4,7\" class=\"abstract_t\">4,7</a>]. In one series, biliary tract disease was associated with half of bacteremias due to <em>S. gallolyticus</em> subspecies <em>pasteurianus</em> and <em>S. infantarius</em>, and 5 percent of bacteremias due to <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Patients with GDS bacteremia should undergo an echocardiogram. This is most critical for patients with bacteremia due to isolates of <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> and isolates not identified to the subspecies level. (See <a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">&quot;Clinical manifestations and evaluation of adults with suspected native valve endocarditis&quot;</a>.)</p><p>An analysis of a large IE isolate database demonstrated that GDS caused 6 percent of infective endocarditis cases (ranging from 10 percent in Europe to 2 percent of cases in North America) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/17\" class=\"abstract_t\">17</a>]. Patients with GDS endocarditis are typically older and less likely than other patients with IE to have predisposing risk factors such as intravenous drug use or structural heart disease. Other issues related to the epidemiology of infection are discussed in detail separately. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H24506924\"><span class=\"h2\">Association with colonic neoplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The association between GDS infection and colonic neoplasia is well described. The association with colonic neoplasia is strongest for <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> (<em>S. bovis</em> biotype I) infections and for cases of IE [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>], but colonic neoplasia has also been observed in the setting of GDS infection at other sites [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2,18\" class=\"abstract_t\">2,18</a>]. The proportion of patients with colonic neoplasia is significantly higher in the setting of GDS IE compared with viridans streptococcal IE (63 versus 18 percent of patients undergoing colonoscopy), but the proportion of patients with colonic carcinoma may be somewhat lower than for patients with <em>Clostridium septicum</em> bacteremia (28 percent had colorectal cancer) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/16,18\" class=\"abstract_t\">16,18</a>]. The reason for this association is not fully understood but may be attributed to the presence of proteins in <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> (<em>S. bovis</em> biotype I) that bind to ligands that are overexpressed in colonic neoplasms. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;</a>.)</p><p>The initial study describing the association noted that <em>S. bovis</em> was recovered from fecal cultures in 56 percent of patients with colon cancer, compared with 10 percent of individuals from a control group with no gastrointestinal disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/19\" class=\"abstract_t\">19</a>]. However, some subsequent studies found no difference in carriage rates between gastrointestinal tract carcinomas and controls [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/20,21\" class=\"abstract_t\">20,21</a>]. These discrepancies may be related to lack of strain identification to the species level subsequently established in the 2003 taxonomy. A study published subsequent to the 2003 taxonomy noted that fecal carriage of GDS was more likely to be due to <em>S. infantarius</em> than <em>S. gallolyticus</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/22\" class=\"abstract_t\">22</a>].</p><p>In studies of patients with GDS bacteremia or endocarditis, colon cancer has been observed in 16 to 32 percent of patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/6,14,15,19,20,23-25\" class=\"abstract_t\">6,14,15,19,20,23-25</a>]. Correlation between GDS infection and other lesions of the gastrointestinal tract has also been described. Adenomas are more commonly associated with GDS infection than carcinomas (median prevalence of 43 versus 18 percent in studies included in a meta-analysis) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>]. Other gastrointestinal tract lesions include premalignant or benign polyps, lymphoma, colitis, and mechanical abnormalities [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/14,15,23,26,27\" class=\"abstract_t\">14,15,23,26,27</a>].</p><p>Variability in the reported incidence of colon cancer in patients with GDS bacteremia or endocarditis may be due to several factors. Differences in organism biotype may be responsible for some of this variability [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2,4,5\" class=\"abstract_t\">2,4,5</a>]. A meta-analysis demonstrated that patients with <em>S. bovis</em> biotype I infection (<em>S. gallolyticus</em> subspecies <em>gallolyticus</em>) had a strongly increased risk of colorectal cancer (pooled OR 7.26; 95% CI 3.94-13.36) and endocarditis (pooled OR 16.61; 95% CI 2.03-6.81) compared with patients with <em>S. bovis</em> biotype II infection (<em>S. gallolyticus</em> subspecies <em>pasteurianus</em> and <em>S. infantarius</em>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"abstract_t\">2</a>]. The rigor of colonic inspection (proportion of patients undergoing full colonoscopy) has been cited as a potential factor in underestimation of the association between GDS bacteremia and colon cancer in some studies [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2,28\" class=\"abstract_t\">2,28</a>]. In addition, the impact of the marked geographic variability in the epidemiology of GDS bacteremia and endocarditis on the probability of colonic lesions is unknown. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;</a>.)</p><p>Identification of GDS bacteremia in adults should prompt colonoscopy to evaluate for carcinoma or other colonic lesions. (See <a href=\"#H1612075403\" class=\"local\">'Colonoscopy'</a> below.)</p><p class=\"headingAnchor\" id=\"H24506986\"><span class=\"h2\">Association with liver disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GDS infection has been associated with liver disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/15,24,29-31\" class=\"abstract_t\">15,24,29-31</a>]. In a study of 199 patients with IE, advanced liver disease (primarily hepatitis C related) was significantly more likely in patients with <em>S. bovis</em> biotype I endocarditis than patients with non-GDS endocarditis (56 versus 15 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29\" class=\"abstract_t\">29</a>]. In the setting of hepatic disease, dysfunction of the reticuloendothelial system may compromise bacterial clearance, allowing entry of organisms into the portal or systemic circulation.</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span></p><p class=\"headingAnchor\" id=\"H1612075351\"><span class=\"h2\">Bacteremia and endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical manifestations of infective endocarditis (IE) due to group D streptococci (GDS) are comparable with manifestations of IE caused by other organisms [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/23,32-36\" class=\"abstract_t\">23,32-36</a>]. The presentation is usually subacute, but occasionally acute onset occurs [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/36\" class=\"abstract_t\">36</a>]. Involvement of more than one valve has been associated with GDS endocarditis more frequently than other oral streptococci (14.0 versus 5.5 percent in one series including 647 cases of streptococcal IE) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29,33,34,37\" class=\"abstract_t\">29,33,34,37</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">&quot;Clinical manifestations and evaluation of adults with suspected native valve endocarditis&quot;</a>.)</p><p>Patients with GDS IE tend to have relatively large vegetations. In a study including 206 patients with definite IE by Duke criteria, vegetations &gt;10 mm were observed more frequently in patients with GDS IE compared with IE caused by other streptococci and nonstreptococcal pathogens (50 percent versus 20 and 34 percent, respectively) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/38\" class=\"abstract_t\">38</a>].</p><p>GDS infection may be highly destructive, resulting in valve perforation or invasive disease with cardiac septal or valvular ring abscess [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/23,32\" class=\"abstract_t\">23,32</a>]. In one case series, infiltration of the left ventricle was more often observed in the setting of IE due to GDS than other causes of IE (36 versus 10 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/34\" class=\"abstract_t\">34</a>]. Patients with GDS in this study were older, had a longer interval prior to diagnosis, and required surgery more often than patients with IE due to other organisms.</p><p>Data are conflicting as to whether embolic events are more common in IE caused by GDS compared with other pathogens [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/23,29,33,34,36,39-42\" class=\"abstract_t\">23,29,33,34,36,39-42</a>]. A few series have noted a predilection for spondylodiscitis as a complication of GDS IE [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/16,29\" class=\"abstract_t\">16,29</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Other sites of infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Biotype II.2 (<em>S. gallolyticus</em> subspecies <em>pasteurianus</em>) has been particularly associated with neonatal sepsis, with or without meningitis; this entity may be clinically indistinguishable from neonatal infection caused by <em>S. agalactiae</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/1,8,43\" class=\"abstract_t\">1,8,43</a>]. In one study including more than 4800 cases of bacterial meningitis in patients &lt;18 years, 23 cases were caused by GDS (0.5 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/44\" class=\"abstract_t\">44</a>]. All were infants, and two-thirds were neonates; most cases occurred in premature infants. When GDS subtype was identified, it was type 2 (<em>Streptococcus gallolyticus pasteurianus</em>) in 80 percent of cases. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex#H2\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;, section on 'Microbiology'</a>.)</p><p>Meningitis has also been described in association with GDS bacteremia and endocarditis in adults [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/18,41,45-48\" class=\"abstract_t\">18,41,45-48</a>]. Such infections are more likely in immunocompromised hosts, including patients with diabetes and chronic renal failure, immunosuppressive therapy, and human immunodeficiency virus infection [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/45,46\" class=\"abstract_t\">45,46</a>] and may be caused by <em>S. gallolyticus</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/48,49\" class=\"abstract_t\">48,49</a>]. </p><p>Other sites of GDS infection include septic arthritis, prosthetic joint infection, vertebral discitis, and endophthalmitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/50-54\" class=\"abstract_t\">50-54</a>]. GDS have also been isolated from a deep neck abscess, infected ascites, and peritoneal dialysis fluid [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/55-57\" class=\"abstract_t\">55-57</a>]. GDS can cause spontaneous bacterial peritonitis in the setting of hepatic cirrhosis, in the absence of colonic neoplasia [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/58,59\" class=\"abstract_t\">58,59</a>]. GDS has been cultured from urine in patients with clinical symptoms of urinary tract infection; the most frequent isolates were <em>S. gallolyticus</em> subspecies <em>pasteurianus</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/60-62\" class=\"abstract_t\">60-62</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of infection due to group D streptococci (GDS) is made via the isolation of the organism from blood, other body fluid, or tissue. Gram-positive cocci that grow on agar in the presence of 40 percent bile and that hydrolyze esculin are very likely to be GDS or enterococci [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/31,63\" class=\"abstract_t\">31,63</a>].</p><p>Determination of the Lancefield group is not usually necessary, nor does it detect all GDS isolates [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/31\" class=\"abstract_t\">31</a>]. GDS typically fail to grow in 6.5 percent NaCl broth, cannot hydrolyze arginine, and are pyrrolidonyl arylamidase negative, which assists in distinguishing it from enterococci [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/5,36\" class=\"abstract_t\">5,36</a>]. Occasionally, streptococci of the viridans group (especially <em>Streptococcus salivarius</em>) are misidentified as <em>S. bovis</em><span class=\"nowrap\">/<em>S</span>. equinus</em>. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;</a>.)</p><p>GDS may be differentiated from viridans streptococci and identified to the <span class=\"nowrap\">species/subspecies</span> level using commercially available kits and automating testing equipment found in most United States clinical microbiology laboratories [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/5,31,64,65\" class=\"abstract_t\">5,31,64,65</a>]. In routine clinical practice, it appears that GDS subspecies identification using matrix-assisted laser <span class=\"nowrap\">desorption/ionization&ndash;time</span> of flight (MALDI-TOF) is as effective, quicker, and less expensive than gene sequencing and may suffice to decide whether echocardiography and colonoscopy should be performed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/11,62,66\" class=\"abstract_t\">11,62,66</a>]. (See <a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex#H2\" class=\"medical medical_review\">&quot;Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)&quot;, section on 'Microbiology'</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">ANTIBIOTIC RESISTANCE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Group D streptococci (GDS) are susceptible to a number of antibiotics and are substantially more susceptible to penicillin and other beta-lactam antibiotics than enterococci (<a href=\"image.htm?imageKey=ID%2F77155%7EID%2F52108\" class=\"graphic graphic_table graphicRef77155 graphicRef52108 \">table 2A-B</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/36\" class=\"abstract_t\">36</a>]. However, some studies have noted minimum inhibitory concentrations (MICs) exceeding &quot;fully susceptible&quot; streptococci for the purposes of selecting treatment for endocarditis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/12,67-69\" class=\"abstract_t\">12,67-69</a>].</p><p>While most strains of GDS appear to be killed at concentrations of penicillin near the MIC [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/36,70\" class=\"abstract_t\">36,70</a>], occasional isolates display tolerance to the lethal effects of penicillin <span class=\"nowrap\">and/or</span> other cell wall&ndash;active agents [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/35,36,71,72\" class=\"abstract_t\">35,36,71,72</a>]. For these isolates, killing measured in vitro is <strong>not</strong> achieved at concentrations that are readily attainable in serum during clinical treatment. However, testing for antibiotic tolerance is not available in most clinical microbiology labs and determination of minimum bactericidal concentrations (MBCs) is not performed routinely.</p><p>Resistance among GDS isolates to non&ndash;beta-lactam antibiotic classes is relatively common [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/73,74\" class=\"abstract_t\">73,74</a>]. Among 128 <em>S. gallolyticus</em> clinical isolates, 78 percent were resistant to tetracyclines, 59 percent to macrolides, 50 percent to <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, 37 percent to <a href=\"topic.htm?path=streptomycin-drug-information\" class=\"drug drug_general\">streptomycin</a>, and 35 percent to <a href=\"topic.htm?path=kanamycin-united-states-not-available-drug-information\" class=\"drug drug_general\">kanamycin</a> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/73\" class=\"abstract_t\">73</a>]. Nearly all of the aminoglycoside-resistant isolates (due to the presence of genes encoding aminoglycoside-modifying enzymes) were also resistant to <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> and <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a>. No isolates in this study were resistant to penicillin, <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, <a href=\"topic.htm?path=rifampin-rifampicin-drug-information\" class=\"drug drug_general\">rifampin</a>, <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a>, teicoplanin, or high-level <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a>, though others have reported high-level resistance to gentamicin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/35,75\" class=\"abstract_t\">35,75</a>].</p><p>Resistance to other agents including <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a> and <a href=\"topic.htm?path=quinupristin-and-dalfopristin-drug-information\" class=\"drug drug_general\">quinupristin-dalfopristin</a> has also been reported (40 to 97 percent and 50 percent, respectively) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29,76\" class=\"abstract_t\">29,76</a>]. GDS are also relatively resistant to the older fluoroquinolones (eg, <a href=\"topic.htm?path=ciprofloxacin-drug-information\" class=\"drug drug_general\">ciprofloxacin</a>); 23 and 54 percent of isolates were resistant in two series [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29,77\" class=\"abstract_t\">29,77</a>].</p><p>Transfer of resistance has been demonstrated in the absence of detectable plasmids and has been attributed to chromosomal resistance markers on conjugative transposon-like elements [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/78\" class=\"abstract_t\">78</a>]. Genomic analysis of an isolate of <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> that caused infective endocarditis demonstrated a mobilizable plasmid conferring <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a> resistance [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/79\" class=\"abstract_t\">79</a>].</p><p>Comparisons between susceptibility reports may be difficult due to variation in geography, collection methods, and typing. There are limited data on species-level susceptibility and subspecies-level differentiation [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/31,80,81\" class=\"abstract_t\">31,80,81</a>]. The various species and subspecies of GDS group generally display similar susceptibility profiles, with susceptibility to penicillins and <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> and higher rates of resistance to non&ndash;beta-lactam agents [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/31,82\" class=\"abstract_t\">31,82</a>].</p><p class=\"headingAnchor\" id=\"H1612075375\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of group D streptococci (GDS) infection is based upon susceptibility data and clinical trials that usually include patients with endocarditis or bacteremia caused by a number of streptococcal species. The approach to treatment is based on a number of factors including antibiotic susceptibility, the presence of prosthetic heart valves or other endovascular material, cardiac complications, evidence of distant septic foci, response to therapy, and individual patient circumstances [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/69,83\" class=\"abstract_t\">69,83</a>]. Drugs of choice for systemic GDS infection include penicillin and <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a>. <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">Vancomycin</a> is the preferred agent for patients with serious allergy to both penicillin and ceftriaxone.</p><p>Tetracyclines, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, macrolides, and <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> may not be active against GDS and are not appropriate for treatment of endocarditis. Although newer fluoroquinolones have enhanced in vitro gram-positive activity (eg, <a href=\"topic.htm?path=moxifloxacin-drug-information\" class=\"drug drug_general\">moxifloxacin</a>), these agents are generally not appropriate for treatment of bacteremia or other invasive infections due to GDS [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/84\" class=\"abstract_t\">84</a>].</p><p><a href=\"topic.htm?path=daptomycin-drug-information\" class=\"drug drug_general\">Daptomycin</a>, <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>, and <a href=\"topic.htm?path=tigecycline-drug-information\" class=\"drug drug_general\">tigecycline</a> are highly active against GDS. Of these, daptomycin may be an alternative for the treatment of GDS bacteremia and endocarditis in the unusual patient who is unable to tolerate beta-lactams or <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/85\" class=\"abstract_t\">85</a>].</p><p class=\"headingAnchor\" id=\"H1612075381\"><span class=\"h2\">Endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Issues related to GDS endocarditis are discussed separately. (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H8\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Viridans streptococci and Streptococcus bovis'</a> and <a href=\"topic.htm?path=antimicrobial-therapy-of-prosthetic-valve-endocarditis#H6\" class=\"medical medical_review\">&quot;Antimicrobial therapy of prosthetic valve endocarditis&quot;, section on 'Streptococci'</a>.)</p><p class=\"headingAnchor\" id=\"H1612075387\"><span class=\"h3\">For MIC &lt;0.5</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Issues related to treatment of native valve endocarditis due to GDS isolates with minimum inhibitory concentration (MIC) of penicillin MIC &lt;0.125 and penicillin MIC &ge;0.125 but &lt;0.5 <span class=\"nowrap\">mcg/mL</span> are summarized in the Tables and are discussed in detail separately (<a href=\"image.htm?imageKey=ID%2F73007\" class=\"graphic graphic_table graphicRef73007 \">table 3</a> and <a href=\"image.htm?imageKey=ID%2F53990\" class=\"graphic graphic_table graphicRef53990 \">table 4</a>). (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H8\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Viridans streptococci and Streptococcus bovis'</a>.)<strong> </strong></p><p>In an early series including 13 patients with <em>S. bovis</em> endocarditis (MIC &le;0.12 <span class=\"nowrap\">mcg/mL)</span> who received treatment with penicillin alone or combined with &le;4 days of <a href=\"topic.htm?path=streptomycin-drug-information\" class=\"drug drug_general\">streptomycin</a> or <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a>, all but one survived [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/36\" class=\"abstract_t\">36</a>]. For treatment of infection due to <em>S. bovis</em> that is not fully susceptible to penicillin (MIC &gt;0.1 <span class=\"nowrap\">mcg/mL),</span> published clinical data are limited; treatment regimens are extrapolated from those used to treat viridans streptococcal endocarditis.</p><p>Short-course (two weeks versus standard four weeks) treatment regimens with once-daily <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> plus once-daily <a href=\"topic.htm?path=gentamicin-drug-information\" class=\"drug drug_general\">gentamicin</a> or netilmicin have been successful in patients with uncomplicated, penicillin-susceptible streptococcal infective endocarditis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/86,87\" class=\"abstract_t\">86,87</a>]. In one study including 18 cases of <em>S. bovis</em> endocarditis, no bacteriologic failures were observed (although there was no control group) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/86\" class=\"abstract_t\">86</a>].</p><p class=\"headingAnchor\" id=\"H1612075392\"><span class=\"h3\">For MIC &ge;0.5</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Native valve endocarditis due to <em>S. bovis</em> isolates with MIC &ge;0.5 <span class=\"nowrap\">mcg/mL</span> is managed as infection due to susceptible enterococcus strains. Treatment is summarized in the Table and is discussed in detail separately (<a href=\"image.htm?imageKey=ID%2F50418\" class=\"graphic graphic_table graphicRef50418 \">table 5</a>). (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H11\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Enterococci'</a>.)</p><p class=\"headingAnchor\" id=\"H1612075398\"><span class=\"h2\">Bacteremia and other infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The optimal management of GDS infection in the absence of endocarditis is uncertain, as data are limited. Patients with GDS bacteremia and meningitis have responded to high-dose penicillin for &ge;2 weeks [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/45\" class=\"abstract_t\">45</a>], and, similarly, <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> is likely active.</p><p class=\"headingAnchor\" id=\"H1612075403\"><span class=\"h2\">Colonoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Given the pronounced association between GDS infection and colonic neoplasia, all adults with GDS infection should undergo colonoscopy. The association between GDS and colonic neoplasm is strongest for <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> and for infective endocarditis cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/24\" class=\"abstract_t\">24</a>]. If negative, colonoscopy should be repeated in four to six months. Evaluation for liver disease and extracolonic malignancy may also be warranted depending on individual circumstances [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29,88\" class=\"abstract_t\">29,88</a>]. (See <a href=\"#H24506924\" class=\"local\">'Association with colonic neoplasia'</a> above.)</p><p class=\"headingAnchor\" id=\"H1612075409\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Streptococcus bovis</em><span class=\"nowrap\">/<em>Streptococcus</span> equinus</em> complex is an important cause of bacteremia and infective endocarditis (IE) in adults. It accounts for 2 to 6 percent of streptococcal bloodstream isolates from hospitalized patients and 6 percent of endocarditis cases worldwide. The gastrointestinal tract is the most likely portal of entry, and group D streptococci (GDS) infection is associated with colonic neoplasia. <em>S. gallolyticus</em> subspecies <em>gallolyticus</em> (<em>S. bovis </em>biotype I) has the strongest association with IE and with colonic neoplasia. (See <a href=\"#H2\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of infection due to GDS is made via the isolation of the organism from blood, other body fluid, or tissue. Gram-positive cocci that grow on agar in the presence of 40 percent bile and that hydrolyze esculin are very likely to be group D streptococci or enterococci. GDS fail to grow in 6.5 percent NaCl broth, cannot hydrolyze arginine, and are pyrrolidonyl arylamidase negative, which assists in distinguishing it from enterococci. Additional biochemical tests, commercial kits, and automated testing can distinguish GDS from viridans streptococci and can discriminate within the <em>S. bovis</em><span class=\"nowrap\">/<em>S</span>. equinus</em> group to the subspecies level. (See <a href=\"#H8\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GDS are substantially more susceptible to penicillin and other beta-lactam antibiotics than enterococci. GDS resistance to non&ndash;beta-lactam antibiotic classes is relatively common. (See <a href=\"#H9\" class=\"local\">'Antibiotic resistance'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Issues related to treatment of native valve endocarditis due to GDS isolates with minimum inhibitory concentration (MIC) &lt;0.5 <span class=\"nowrap\">mcg/mL</span> are summarized in the Tables and are discussed in detail separately (<a href=\"image.htm?imageKey=ID%2F73007\" class=\"graphic graphic_table graphicRef73007 \">table 3</a> and <a href=\"image.htm?imageKey=ID%2F53990\" class=\"graphic graphic_table graphicRef53990 \">table 4</a>). (See <a href=\"#H1612075381\" class=\"local\">'Endocarditis'</a> above and <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H8\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Viridans streptococci and Streptococcus bovis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Native valve endocarditis due to GDS isolates with MIC &ge;0.5 <span class=\"nowrap\">mcg/mL</span> is managed as infection due to susceptible enterococcus strains. Treatment is summarized in the Table and is discussed in detail separately (<a href=\"image.htm?imageKey=ID%2F50418\" class=\"graphic graphic_table graphicRef50418 \">table 5</a>). (See <a href=\"#H1612075381\" class=\"local\">'Endocarditis'</a> above and <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis#H11\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;, section on 'Enterococci'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For treatment of penicillin-susceptible GDS infection in the absence of endocarditis, we suggest <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> (1 to 2 g once daily for most infections, 2 g twice a day for meningitis) or penicillin (12 to 24 million units intravenously daily, divided every four hours) (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>); the appropriate duration is at least two weeks. (See <a href=\"#H1612075398\" class=\"local\">'Bacteremia and other infections'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We recommend that all adults with GDS bacteremia undergo colonoscopy (<a href=\"grade.htm?i=1\" class=\"grade\">Grade 1A</a>). If negative, colonoscopy should be repeated in four to six months. Evaluation for liver disease and extracolonic malignancy may also be warranted depending on individual circumstances. (See <a href=\"#H24506924\" class=\"local\">'Association with colonic neoplasia'</a> above and <a href=\"#H1612075403\" class=\"local\">'Colonoscopy'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H5373757\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Howard Gold, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/1\" class=\"nounderline abstract_t\">Klatte JM, Clarridge JE 3rd, Bratcher D, Selvarangan R. A longitudinal case series description of meningitis due to Streptococcus gallolyticus subsp. pasteurianus in infants. J Clin Microbiol 2012; 50:57.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/2\" class=\"nounderline abstract_t\">Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011; 53:870.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/3\" class=\"nounderline abstract_t\">van't Wout JW, Bijlmer HA. Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology. Clin Infect Dis 2005; 40:1070.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/4\" class=\"nounderline abstract_t\">Corredoira JC, Alonso MP, Garc&iacute;a JF, et al. Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis 2005; 24:250.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/5\" class=\"nounderline abstract_t\">Ruoff KL, Miller SI, Garner CV, et al. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 1989; 27:305.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/6\" class=\"nounderline abstract_t\">Corredoira-S&aacute;nchez J, Garc&iacute;a-Garrote F, Rabu&ntilde;al R, et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis 2012; 55:491.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/7\" class=\"nounderline abstract_t\">Fern&aacute;ndez-Ruiz M, Villar-Silva J, Llenas-Garc&iacute;a J, et al. Streptococcus bovis bacteraemia revisited: clinical and microbiological correlates in a contemporary series of 59 patients. J Infect 2010; 61:307.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/8\" class=\"nounderline abstract_t\">Floret N, Bailly P, Thouverez M, et al. A cluster of bloodstream infections caused by Streptococcus gallolyticus subspecies pasteurianus that involved 5 preterm neonates in a university hospital during a 2-month period. Infect Control Hosp Epidemiol 2010; 31:194.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/9\" class=\"nounderline abstract_t\">Jans C, Meile L, Lacroix C, Stevens MJ. Genomics, evolution, and molecular epidemiology of the Streptococcus bovis/Streptococcus equinus complex (SBSEC). Infect Genet Evol 2015; 33:419.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/10\" class=\"nounderline abstract_t\">Saegeman V, Cossey V, Loens K, et al. Streptococcus Gallolyticus Subsp. Pasteurianus Infection In A Neonatal Intensive Care Unit. Pediatr Infect Dis J 2016; 35:1272.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/11\" class=\"nounderline abstract_t\">Ben-Chetrit E, Wiener-Well Y, Kashat L, et al. Streptococcus bovis new taxonomy: does subspecies distinction matter? Eur J Clin Microbiol Infect Dis 2017; 36:387.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/12\" class=\"nounderline abstract_t\">Pfaller MA, Jones RN, Marshall SA, et al. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 1997; 29:259.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/13\" class=\"nounderline abstract_t\">Eggers S, Beuth J. Etiology and antibiotic susceptibility of bloodstream Streptococcus sp. Zentralbl Bakteriol 1992; 276:521.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/14\" class=\"nounderline abstract_t\">Murray HW, Roberts RB. Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 1978; 138:1097.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/15\" class=\"nounderline abstract_t\">Zarkin BA, Lillemoe KD, Cameron JL, et al. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg 1990; 211:786.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/16\" class=\"nounderline abstract_t\">Corredoira J, Alonso MP, Coira A, et al. Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis 2008; 27:285.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/17\" class=\"nounderline abstract_t\">Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/18\" class=\"nounderline abstract_t\">Panwalker AP. Unusual infections associated with colorectal cancer. Rev Infect Dis 1988; 10:347.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/19\" class=\"nounderline abstract_t\">Klein RS, Recco RA, Catalano MT, et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297:800.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/20\" class=\"nounderline abstract_t\">Klein RS, Catalano MT, Edberg SC, et al. Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 1979; 91:560.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/21\" class=\"nounderline abstract_t\">Potter MA, Cunliffe NA, Smith M, et al. A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 1998; 51:473.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/22\" class=\"nounderline abstract_t\">Chirouze C, Patry I, Duval X, et al. Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection. Eur J Clin Microbiol Infect Dis 2013; 32:1171.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/23\" class=\"nounderline abstract_t\">Ballet M, Gevigney G, Gar&eacute; JP, et al. Infective endocarditis due to Streptococcus bovis. A report of 53 cases. Eur Heart J 1995; 16:1975.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/24\" class=\"nounderline abstract_t\">Alazmi W, Bustamante M, O'Loughlin C, et al. The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. Dig Dis Sci 2006; 51:732.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/25\" class=\"nounderline abstract_t\">Leport C, Bure A, Leport J, Vilde JL. Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1987; 1:748.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/26\" class=\"nounderline abstract_t\">Burns CA, McCaughey R, Lauter CB. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 1985; 80:42.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/27\" class=\"nounderline abstract_t\">Moshkowitz M, Arber N, Wajsman R, et al. Streptococcus bovis endocarditis as a presenting manifestation of idiopathic ulcerative colitis. Postgrad Med J 1992; 68:930.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/28\" class=\"nounderline abstract_t\">Boleij A, Schaeps RM, Tjalsma H. Association between Streptococcus bovis and colon cancer. J Clin Microbiol 2009; 47:516.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/29\" class=\"nounderline abstract_t\">Tripodi MF, Adinolfi LE, Ragone E, et al. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 2004; 38:1394.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/30\" class=\"nounderline abstract_t\">Lee RA, Woo PC, To AP, et al. Geographical difference of disease association in Streptococcus bovis bacteraemia. J Med Microbiol 2003; 52:903.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/31\" class=\"nounderline abstract_t\">Beck M, Frodl R, Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol 2008; 46:2966.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/32\" class=\"nounderline abstract_t\">Hoen B, Chirouze C, Cabell CH, et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 2005; 24:12.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/33\" class=\"nounderline abstract_t\">Ravreby WD, Bottone EJ, Keusch GT. Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infections due to Streptococcus bovis. N Engl J Med 1973; 289:1400.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/34\" class=\"nounderline abstract_t\">Kupferwasser I, Darius H, M&uuml;ller AM, et al. Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 1998; 80:276.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/35\" class=\"nounderline abstract_t\">Duval X, Papastamopoulos V, Longuet P, et al. Definite streptococcus bovis endocarditis: characteristics in 20 patients. Clin Microbiol Infect 2001; 7:3.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/36\" class=\"nounderline abstract_t\">Moellering RC Jr, Watson BK, Kunz LJ. Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci. Am J Med 1974; 57:239.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/37\" class=\"nounderline abstract_t\">Bassetti M, Secchi G, Borziani S, et al. Successful treatment of four-valve native endocarditis caused by Streptococcus bovis. Int J Cardiol 2004; 97:159.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/38\" class=\"nounderline abstract_t\">Pergola V, Di Salvo G, Habib G, et al. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol 2001; 88:871.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/39\" class=\"nounderline abstract_t\">Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288:75.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/40\" class=\"nounderline abstract_t\">Gonzlez-Quintela A, Mart&iacute;nez-Rey C, Castroagud&iacute;n JF, et al. Prevalence of liver disease in patients with Streptococcus bovis bacteraemia. J Infect 2001; 42:116.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/41\" class=\"nounderline abstract_t\">Gergaud JM, Breux JP, Roblot P, et al. [Neurologic complications of infectious endocarditis]. Ann Med Interne (Paris) 1995; 146:413.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/42\" class=\"nounderline abstract_t\">Giannitsioti E, Chirouze C, Bouvet A, et al. Characteristics and regional variations of group D streptococcal endocarditis in France. Clin Microbiol Infect 2007; 13:770.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/43\" class=\"nounderline abstract_t\">Hede SV. Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group. Curr Infect Dis Rep 2016; 18:11.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/44\" class=\"nounderline abstract_t\">Beneteau A, Levy C, Foucaud P, et al. Childhood meningitis caused by Streptococcus bovis group: clinical and biologic data during a 12-year period in France. Pediatr Infect Dis J 2015; 34:136.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/45\" class=\"nounderline abstract_t\">Cohen LF, Dunbar SA, Sirbasku DM, Clarridge JE 3rd. Streptococcus bovis infection of the central nervous system: report of two cases and review. Clin Infect Dis 1997; 25:819.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/46\" class=\"nounderline abstract_t\">Jain AK, Agarwal SK, el-Sadr W. Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1994; 18:253.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/47\" class=\"nounderline abstract_t\">Coret Ferrer F, Vilchez Padilla JJ, Igual Adell R, Ferrando Ginestar J. Streptococcus bovis meningitis: no association with colonic malignancy. Clin Infect Dis 1993; 17:527.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/48\" class=\"nounderline abstract_t\">van Samkar A, Brouwer MC, Pannekoek Y, et al. Streptococcus gallolyticus meningitis in adults: report of five cases and review of the literature. Clin Microbiol Infect 2015; 21:1077.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/49\" class=\"nounderline abstract_t\">Gray JD, Wilson CJ. Streptococcus gallolyticus (bovis): a rare presentation of meningitis in the ED. Am J Emerg Med 2016; 34:677.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/50\" class=\"nounderline abstract_t\">Grant RJ, Shang WY, Whitehead TR. Isolated septic arthritis due to Streptococcus bovis. Clin Infect Dis 1997; 24:1021.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/51\" class=\"nounderline abstract_t\">Emerton ME, Crook DW, Cooke PH. Streptococcus bovis-infected total hip arthroplasty. J Arthroplasty 1995; 10:554.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/52\" class=\"nounderline abstract_t\">Bajwa ZH, Ho C, Grush A, et al. Discitis associated with pregnancy and spinal anesthesia. Anesth Analg 2002; 94:415.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/53\" class=\"nounderline abstract_t\">Bleibel W, D'Silva K, Elhorr A, et al. Streptococcus bovis endophthalmitis: a unique presentation of colon cancer. Dig Dis Sci 2007; 52:2336.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/54\" class=\"nounderline abstract_t\">Garc&iacute;a-Pa&iacute;s MJ, Rabu&ntilde;al R, Armesto V, et al. Streptococcus bovis septic arthritis and osteomyelitis: A report of 21 cases and a literature review. Semin Arthritis Rheum 2016; 45:738.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/55\" class=\"nounderline abstract_t\">Goumas PD, Naxakis SS, Rentzis GA, et al. Lateral neck abscess caused by Streptococcus bovis in a patient with undiagnosed colon cancer. J Laryngol Otol 1997; 111:666.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/56\" class=\"nounderline abstract_t\">Ackerman Z, Eliakim R, Stalnikowicz R. Spontaneous peritonitis caused by Streptococcus bovis: search for colonic neoplasia. J Clin Gastroenterol 1995; 21:263.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/57\" class=\"nounderline abstract_t\">Wong SS, Woo PC, Ho PL, Wang TK. Continuous ambulatory peritoneal dialysis-related peritonitis caused by Streptococcus bovis. Eur J Clin Microbiol Infect Dis 2003; 22:424.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/58\" class=\"nounderline abstract_t\">Eledrisi MS, Zuckerman MJ, Ho H. Spontaneous bacterial peritonitis caused by Streptococcus bovis. Am J Gastroenterol 2000; 95:1110.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/59\" class=\"nounderline abstract_t\">Genuth L. Re: Shad and Schindler's report on spontaneous peritonitis due to Streptococcus bovis. Am J Gastroenterol 2000; 95:840.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/60\" class=\"nounderline abstract_t\">Matesanz M, Rubal D, I&ntilde;iguez I, et al. Is Streptococcus bovis a urinary pathogen? Eur J Clin Microbiol Infect Dis 2015; 34:719.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/61\" class=\"nounderline abstract_t\">de Teresa-Alguacil J, Guti&eacute;rrez-Soto M, Rodr&iacute;guez-Granger J, et al. Clinical interest of Streptococcus bovis isolates in urine. Rev Esp Quimioter 2016; 29:155.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/62\" class=\"nounderline abstract_t\">Gherardi G, Palmieri C, Marini E, et al. Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus. Diagn Microbiol Infect Dis 2016; 86:329.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/63\" class=\"nounderline abstract_t\">Chuard C, Reller LB. Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time. J Clin Microbiol 1998; 36:1135.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/64\" class=\"nounderline abstract_t\">Clarridge JE 3rd, Attorri SM, Zhang Q, Bartell J. 16S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis Biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males. J Clin Microbiol 2001; 39:1549.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/65\" class=\"nounderline abstract_t\">Haanper&auml; M, Jalava J, Huovinen P, et al. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol 2007; 45:762.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/66\" class=\"nounderline abstract_t\">Dekker JP, Lau AF. An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations. J Clin Microbiol 2016; 54:1694.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/67\" class=\"nounderline abstract_t\">Mouton JW, Endtz HP, den Hollander JG, et al. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. J Antimicrob Chemother 1997; 39 Suppl A:75.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/68\" class=\"nounderline abstract_t\">Matsumura M, Araki T, Yokogawa A. Streptococcus bovis discitis and possible endocarditis. Intern Med 2000; 39:677.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/69\" class=\"nounderline abstract_t\">Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/70\" class=\"nounderline abstract_t\">Thornsberry C, Baker CN, Facklam RR. Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother 1974; 5:228.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/71\" class=\"nounderline abstract_t\">Fung JC, Gadbaw JJ Jr, Donta ST, Tilton RC. Infective endocarditis due to penicillin-tolerant Streptococcus bovis. Diagn Microbiol Infect Dis 1986; 5:171.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/72\" class=\"nounderline abstract_t\">Venditti M, Gelfusa V, Serra P, et al. 4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin. Antimicrob Agents Chemother 1992; 36:723.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/73\" class=\"nounderline abstract_t\">Leclercq R, Huet C, Picherot M, et al. Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother 2005; 49:1646.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/74\" class=\"nounderline abstract_t\">Rodr&iacute;guez-Avial I, Rodr&iacute;guez-Avial C, Culebras E, Picazo JJ. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Antimicrob Agents Chemother 2005; 49:820.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/75\" class=\"nounderline abstract_t\">Kaufhold A, Potgieter E. Chromosomally mediated high-level gentamicin resistance in Streptococcus mitis. Antimicrob Agents Chemother 1993; 37:2740.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/76\" class=\"nounderline abstract_t\">Teng LJ, Hsueh PR, Ho SW, Luh KT. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob Agents Chemother 2001; 45:3362.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/77\" class=\"nounderline abstract_t\">Kerawala M, Ambler JE, Lee PY, Drabu YJ. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2001; 20:271.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/78\" class=\"nounderline abstract_t\">David F, de C&eacute;sp&egrave;des G, Delbos F, Horaud T. Diversity of chromosomal genetic elements and gene identification in antibiotic-resistant strains of Streptococcus pneumoniae and Streptococcus bovis. Plasmid 1993; 29:147.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/79\" class=\"nounderline abstract_t\">Hinse D, Vollmer T, R&uuml;ckert C, et al. Complete genome and comparative analysis of Streptococcus gallolyticus subsp. gallolyticus, an emerging pathogen of infective endocarditis. BMC Genomics 2011; 12:400.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/80\" class=\"nounderline abstract_t\">Moet GJ, Dowzicky MJ, Jones RN. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci. Diagn Microbiol Infect Dis 2007; 57:333.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/81\" class=\"nounderline abstract_t\">Romero B, Morosini MI, Loza E, et al. Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue? J Clin Microbiol 2011; 49:3228.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/82\" class=\"nounderline abstract_t\">Tripodi MF, Fortunato R, Utili R, et al. Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbiol Infect 2005; 11:814.</a></li><li class=\"breakAll\">Roberts RB. Streptococcal endocarditis: The viridans and beta hemolytic streptococci. In: Infective Endocarditis, Kaye D (Ed), Raven Press, New York 1992. p.191.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/84\" class=\"nounderline abstract_t\">Hoogkamp-Korstanje JA, Roelofs-Willemse J. Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother 2000; 45:31.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/85\" class=\"nounderline abstract_t\">Streit JM, Steenbergen JN, Thorne GM, et al. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 2005; 55:574.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/86\" class=\"nounderline abstract_t\">Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995; 21:1406.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/87\" class=\"nounderline abstract_t\">Sexton DJ, Tenenbaum MJ, Wilson WR, et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 1998; 27:1470.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex/abstract/88\" class=\"nounderline abstract_t\">Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139:760.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3156 Version 16.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1612075409\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H24505889\" id=\"outline-link-H24505889\">CLINICAL ASSOCIATIONS</a><ul><li><a href=\"#H24505897\" id=\"outline-link-H24505897\">Association with endocarditis</a></li><li><a href=\"#H24506924\" id=\"outline-link-H24506924\">Association with colonic neoplasia</a></li><li><a href=\"#H24506986\" id=\"outline-link-H24506986\">Association with liver disease</a></li></ul></li><li><a href=\"#H2\" id=\"outline-link-H2\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H1612075351\" id=\"outline-link-H1612075351\">Bacteremia and endocarditis</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Other sites of infection</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">DIAGNOSIS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">ANTIBIOTIC RESISTANCE</a></li><li><a href=\"#H1612075375\" id=\"outline-link-H1612075375\">TREATMENT</a><ul><li><a href=\"#H1612075381\" id=\"outline-link-H1612075381\">Endocarditis</a><ul><li><a href=\"#H1612075387\" id=\"outline-link-H1612075387\">- For MIC &lt;0.5</a></li><li><a href=\"#H1612075392\" id=\"outline-link-H1612075392\">- For MIC &ge;0.5</a></li></ul></li><li><a href=\"#H1612075398\" id=\"outline-link-H1612075398\">Bacteremia and other infections</a></li><li><a href=\"#H1612075403\" id=\"outline-link-H1612075403\">Colonoscopy</a></li></ul></li><li><a href=\"#H1612075409\" id=\"outline-link-H1612075409\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H5373757\" id=\"outline-link-H5373757\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3156|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/89670\" class=\"graphic graphic_table\">- Group D Streptococcus nomenclature</a></li><li><a href=\"image.htm?imageKey=ID/77155\" class=\"graphic graphic_table\">- Strep bovis susceptibilities I</a></li><li><a href=\"image.htm?imageKey=ID/52108\" class=\"graphic graphic_table\">- Strep bovis susceptibilities II</a></li><li><a href=\"image.htm?imageKey=ID/73007\" class=\"graphic graphic_table\">- Rx strep NVE I</a></li><li><a href=\"image.htm?imageKey=ID/53990\" class=\"graphic graphic_table\">- Rx strep NVE II</a></li><li><a href=\"image.htm?imageKey=ID/50418\" class=\"graphic graphic_table\">- Rx EC IE (S to PCN and gent)</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-prosthetic-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of prosthetic valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">Clinical manifestations and evaluation of adults with suspected native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-pathogenesis-and-epidemiology-of-infections-due-to-group-d-streptococci-streptococcus-bovis-streptococcus-equinus-complex\" class=\"medical medical_review\">Microbiology, pathogenesis, and epidemiology of infections due to group D streptococci (Streptococcus bovis/Streptococcus equinus complex)</a></li></ul></div></div>","javascript":null}